Alcon Inc. ALC
74.94 USD -1.61 (-2.10%)
At closeNov 9, 2026, 7:37 AM EST
74.90 -0.04 -0.05%
Pre-market · Nov 9, 7:37 AM ET
74.01 Day range 75.23
61.84 52-week range 87.64
- YTD
- -4.91%
- 1 year
- +0.90%
News
businesswire.com Algoma Central Corporation Announces Closing of Over-Allotment Option of Additional Debentures ST. CATHARINES, Ontario--(BUSINESS WIRE)--Algoma Central Corporation (“Algoma”) (TSX:ALC) is pleased to announce that, in connection with its previously announced offering (the “Public Offering”) of…
businesswire.com Algoma Central Corporation Reports Financial Results for the 2026 Third Quarter ST. CATHARINES, Ontario--(BUSINESS WIRE)--Algoma Central Corporation (TSX: ALC) ("Algoma", the "Company") today reported its results for the three and nine months ended September 30, 2026. Algoma…
zacks.com Alcon (ALC) Surges 6.8%: Is This an Indication of Further Gains? Alcon (ALC) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
seekingalpha.com Higher Margins, Better ROIC And Capable Management Define Pershing Square's Q3 2026 Portfolio We seek to purchase our target companies at share prices that incorporate a margin of safety. We estimate that the companies in PSH's investment portfolio will have average annual EPS growth of about…
benzinga.com Keybanc Maintains Overweight on Alcon, Lowers Price Target to $84 Keybanc analyst Brett Fishbin maintains Alcon (NYSE:ALC) with a Overweight and lowers the price target from $88 to $84.
benzinga.com Alcon Acquires Neurotech Pharmaceuticals For $550M Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced it has acquired Neurotech Pharmaceuticals, Inc., a company focused on developing…
benzinga.com Alcon Announces FDA Approval For BRYTLY Redness Relief Eye Drops, Expanding Over The Counter Eye Care Portfolio. One drop works to significantly reduce redness, with results lasting up to 12 hours1Lasts up to 50% longer than Lumify1-2,*Expands Alcon's portfolio of consumer eye care solutions and will be…
benzinga.com Barclays Initiates Coverage On Alcon with Equal-Weight Rating, Announces Price Target of $70 Barclays analyst Christopher Pasquale initiates coverage on Alcon (NYSE:ALC) with a Equal-Weight rating and announces Price Target of $70.
benzinga.com Trump Expands Drug Pricing Deals With 9 Pharma Companies, Bringing Total to 26 — RFK Jr. Details 'Very, Very Emotional' Conversations With President Trump secures drug pricing deals with nine pharma companies as Kennedy reveals intense pressure from the President to deliver.
benzinga.com Why Is Netflix Stock Falling on Monday? Netflix Inc. (NASDAQ: NFLX) stock slips as market concerns over third-quarter revenue and earnings guidance outweigh Bill Ackman's new Pershing Square stake.
benzinga.com Bill Ackman’s New Stock Picks Are Here. These ETFs Could Be Worth Watching Bill Ackman's new stock picks include Netflix, Visa and Mastercard. ETF investors can get fresh exposure through VFH, XLC and IAI.
benzinga.com Bill Ackman Lost $400 Million on NFLX Stock in 2022 — Now He’s Back With a 3.15M-Share Bet, Saying Netflix Has ‘Won the Streaming Wars’ (UPDATED) Bill Ackman’s Pershing Square re-enters Netflix with a 3.15M share stake, declaring the streaming wars won after a historic 2022 loss.
benzinga.com JP Morgan Maintains Neutral on Alcon, Raises Price Target to $78.4 JP Morgan analyst David Adlington maintains Alcon (NYSE:ALC) with a Neutral and raises the price target from $77.53 to $78.4.
benzinga.com Mizuho Maintains Outperform on Alcon, Raises Price Target to $85 Mizuho analyst Anthony Petrone maintains Alcon (NYSE:ALC) with a Outperform and raises the price target from $80 to $85.
benzinga.com National CineMedia Posts Downbeat Q2 Results, Joins Borr Drilling, AbCellera Biologics And Other Big Stocks Moving Lower In Wednesday’s Pre-Market Session U.S. stock futures higher, Nasdaq 100 up 150 pts. National CineMedia shares down 16.4% on weak Q2 results and Captivate Holdings acquisition. Other stocks also falling in pre-market trading.
benzinga.com 12 Health Care Stocks Moving In Monday's After-Market Session Gainers P3 Health Partners (NASDAQ:PIII) shares increased by 24.1% to $15.92 during Monday's after-market session. The market value of their outstanding shares is at $38.5 million. As per the press…
benzinga.com Alcon Raises FY2026 Adj EPS Guidance from $3.38-$3.47 to $3.44-$3.53 vs $3.41 Est; Widens FY2026 Sales Guidance of $10.835B-$11.041B vs $11.087B Est Alcon (NYSE:ALC) raises FY2026 Adj EPS guidance from $3.38-$3.47 to $3.44-$3.53 vs $3.41 analyst estimate. Widens FY2026 sales outlook from $10.835 billion-$11.041 billion to $10.835 billion-$11.041…
benzinga.com Alcon Q2 Adj. EPS $0.84 Beats $0.75 Estimate, Sales $2.782B Beat $2.769B Estimate Alcon (NYSE:ALC) reported quarterly earnings of $0.84 per share which beat the analyst consensus estimate of $0.75 by 12 percent. This is a 10.53 percent increase over earnings of $0.76 per share…
benzinga.com S&P 500 Surges To Record Close Following Jobs Data: Investor Sentiment Improves, Fear Index Remains in ‘Greed’ Zone U.S. stocks closed higher, with Nasdaq up 300 points. S&P 500 and Nasdaq rose for the second consecutive week. Fear & Greed index in Greed zone.
benzinga.com Aecom, Alcon And 3 Stocks To Watch Heading Into Monday U.S. stock futures mixed, Aecom and Hawaiian Electric report earnings, Alcon expected to release earnings, Check Cap announces reverse split, Monday.Com expected to post earnings.- benzinga.com Mizuho Maintains Outperform on Alcon, Lowers Price Target to $80 Mizuho analyst Anthony Petrone maintains Alcon (NYSE:ALC) with a Outperform and lowers the price target from $85 to $80.
- benzinga.com Alcon And RxSight Announce A Non-Exclusive Collaboration To Jointly Develop Adjustable Presbyopia-Correcting Intraocular Lenses Alcon (NYSE:ALC), the global leader in eye care dedicated to helping people see brilliantly, and RxSight, Inc. (NASDAQ:RXST), an ophthalmic medical device company dedicated to providing high-quality…
benzinga.com Zoetis, Insmed, And HubSpot Are Among Top 10 Large-Cap Losers Last Week (May 4-May 8): Are The Others In Your Portfolio? Weak earnings, soft guidance and analyst target cuts triggered sharp selloffs across healthcare, software, networking and industrial stocks last week, led by Zoetis, Insmed and HubSpot.
benzinga.com Barclays Maintains Equal-Weight on Alcon, Lowers Price Target to $78 Barclays analyst Matt Miksic maintains Alcon (NYSE:ALC) with a Equal-Weight and lowers the price target from $90 to $78.
benzinga.com Earnings Scheduled For May 5, 2026 - benzinga.com Earnings Scheduled For March 5, 2026
benzinga.com Nvidia To Rally More Than 53%? Here Are 10 Top Analyst Forecasts For Thursday - benzinga.com Earnings Scheduled For February 24, 2026
benzinga.com FDA Expands Approval For Staar Surgical's Popular Implantable Lens FDA expands Staar Surgical's EVO ICL approval for ages 21-60, offering a safer, non-LASIK alternative to millions.
benzinga.com STAAR Surgical Stock Falls After Largest Shareholder Broadwood Gains Board Influence STAAR Surgical shares fell Thursday as new directors joined the board, key leaders exited, and Broadwood Partners pushed for changes following the failed Alcon merger.
benzinga.com Stock Market Today: Nasdaq, Dow Jones, S&P 500 Futures Rise Ahead Of House Vote To Reopen Government— Bill Holdings, AMD, Cisco In Focus (UPDATED) (Editor’s note: The future prices of benchmark tracking ETFs and the headline were updated in the story.) U.S. stock futures rose on Wednesday after Tuesday’s mixed close. Futures of major benchmark…
benzinga.com Alcon, Cisco Systems And 3 Stocks To Watch Heading Into Wednesday US stock futures up, IHS and Alcon report positive earnings, Cisco and CAE also expected to do well, On Holding disappoints.
benzinga.com Palantir, Reddit, And Intuit Are Among Top 10 Large Cap Losers Last Week (August 18-August 22): Are The Others In Your Portfolio? These ten large-cap stocks were the worst performers last week. Are they a part of your portfolio?
benzinga.com La-Z-Boy Posts Downbeat Q1 Results, Joins James Hardie Industries, Alcon And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session 
benzinga.com Why Rocket Pharmaceuticals Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket - benzinga.com 12 Health Care Stocks Moving In Tuesday's After-Market Session
- benzinga.com Earnings Scheduled For August 19, 2025
- benzinga.com 10 Health Care Stocks With Whale Alerts In Today's Session
benzinga.com Alcon, American Eagle, GRAIL And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session 
benzinga.com American Eagle, Cisco Systems And 3 Stocks To Watch Heading Into Wednesday - benzinga.com Earnings Scheduled For May 13, 2025
- benzinga.com Earnings Scheduled For February 25, 2025
- benzinga.com Earnings Scheduled For November 12, 2024
benzinga.com Why Alibaba Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session - benzinga.com Earnings Scheduled For November 14, 2023 Companies Reporting Before The Bell • CureVac (NASDAQ:CVAC) is likely to report quarterly loss at $0.24 per share on revenue of $18.00 million.
- benzinga.com Earnings Scheduled For November 15, 2022 Companies Reporting Before The Bell • Alkaline Water Co (NASDAQ:WTER) is likely to report quarterly loss at $0.05 per share on revenue of $18.31 million.
- benzinga.com Stocks That Hit 52-Week Lows On Thursday On Thursday, 930 stocks hit new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Thursday On Thursday, 1076 companies hit new 52-week lows.
- benzinga.com Earnings Scheduled For August 9, 2022 Companies Reporting Before The Bell • Cognition Therapeutics (NASDAQ:CGTX) is estimated to report earnings for its second quarter.
- benzinga.com Earnings Scheduled For May 10, 2022 Companies Reporting Before The Bell • The Middleby (NASDAQ:MIDD) is expected to report quarterly earnings at $2.10 per share on revenue of $935.99 million.